Difference In Pill Color May Affect Patient's Adherence

Extra warnings might help

That is interesting. In my personal experience I've been aware people stop generics more often then brand names.

I'm pretty sure it's because they believe they're getting a slightly inferior product and it makes them nervous. The irony is that the generic was less aggressively marketed, and safer because more data has been published by the time the original patent expired.

However, drugs that affect closed systems that have feedback are the real culprit. Feedback mechanisms in Neurotransmitter pathways are absolutely required for information processing to occur properly. Psychotropic drugs external disrupt these pathways and feedback will progressively become non-uniform from neuron to neuron and cause drug dependence. Stopping the drug makes the illness worse, if it doesn't create new worse problems outright.

Honestly I don't what to make of it. I think it's better that the color lowers the duration a patient will take a drug that progressively screws information processing as a system in their brain. We shouldn't want to change that. After all, if they choose to stop it they're obviously not ill enough to want to continue it. It's disturbing to trick people in drugging themselves for no reason, isn't it?

Frankly they should just print warning on the package "Don't stop this drug immediately, it must be tapered". If only addressing over prescriptions was as easy as making the product ugly.

| post followup | alert a moderator |